Latest Asx Listing Rules News

Linius Technologies has addressed a late filing of a director's interest notice, attributing the delay to an administrative oversight involving a new class of securities. The company has updated its processes and will re-brief directors to ensure future compliance.

Platina Resources Limited has addressed ASX concerns over a sharp rise in its share price and trading volume, confirming no undisclosed information is driving the activity. The company points to recent project acquisition and heritage clearance announcements as possible catalysts.

Noble Helium Limited remains suspended from trading as it works through legacy issues delaying its 2025 audited Annual Report. The company is collaborating closely with auditors to resolve outstanding matters and aims to lodge the report promptly.

Flynn Gold Limited’s FG1OA securities have been suspended from trading due to non-compliance with ASX listing rules, raising questions about the company’s regulatory standing.

Anatara Lifesciences has raised $1.2 million through a discounted share placement to fund its Anti-Obesity project and explore new opportunities. The capital injection reflects strong institutional support amid ongoing pipeline development.

Nelson Resources has confirmed it is in confidential negotiations for a Right to Mine contract, explaining recent unusual trading activity in its shares. The company maintains compliance with ASX disclosure rules while awaiting contract finalisation.

Yowie Group Limited has extended and increased its secured working capital loan facility with Keybridge Capital, adjusting terms to support ongoing liquidity.

PARKD Limited has completed the first tranche of its $0.78 million placement, issuing over 20 million shares at 3 cents each, while launching a Share Purchase Plan for existing shareholders.

Lord Resources has completed a $814,000 placement by issuing 22 million shares, reinforcing its funding position as it advances exploration at the Ilgarari Copper Project in Western Australia.

Myer Holdings has clarified that its FY2025 earnings aligned with market forecasts, addressing concerns following a sharp share price drop after its results announcement.

Invex Therapeutics reveals the collapse of confidential acquisition negotiations following shareholder unrest and potential board changes, clarifying recent unusual trading activity.

Hydrix Limited delays its FY25 financial statements due to a pending independent valuation of its Wavewise Analytics shareholding, triggering an automatic trading suspension from 1 October 2025.